Different types of genetic alterations, which ranged from aneuploidy and overall genetic imbalance in DS; to point genetic mutations affecting different processes or signaling pathways, such as the metabolism of mucopolysaccharides in MS, and the RAS/MAPK pathway in NS and NF1, significantly affected the facial phenotypes. The gene discussed is NF1; the disease is myeloid sarcoma.